# Renin Angiotensin System Study (RASS/B-RASS)

> **NCT00143949** · PHASE2 · COMPLETED · sponsor: **Michael Mauer, MD** · enrollment: 285 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** enalapril
- **DRUG:** losartan

## Key facts

- **NCT ID:** NCT00143949
- **Lead sponsor:** Michael Mauer, MD
- **Sponsor class:** INDIV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-03
- **Primary completion:** 2007-03
- **Final completion:** 2008-05
- **Target enrollment:** 285 (ACTUAL)
- **Last updated:** 2008-11-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00143949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00143949, "Renin Angiotensin System Study (RASS/B-RASS)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00143949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*